Patient-centered Communication About Healthy Weight in Early Breast Cancer

NCT ID: NCT04504201

Last Updated: 2022-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

39 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-15

Study Completion Date

2020-09-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comorbidities in breast cancer survival account for 49% of overall survival difference between black and white women. Many obesity-related comorbidities disproportionately affect black women, therefore pointing to a need to address obesity related comorbidities in survival disparities in early breast cancer patients. This study tinvestigates how messages and messaging about healthy weight can be tailored for racially diverse breast cancer survivors with obesity in order to ensure that clinic-based communications between patients and their oncology provider are patient-centered and culturally sensitive.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The overall goal of this research is to collect essential input for the future development of a quality improvement intervention to foster "Patient-Center Communication about Healthy Weigh in clinical practice

Primary Objective:

1. Understand patient-centered perspectives on health weight communication with oncology clinicians by conducting focus groups

Secondary Objective
2. Understand oncology clinician perspectives on patient center communications for healthy weight interactions through semi-structured interviews.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early Breast Cancer Patients

Early breast cancer patients (Stage I-III) who have completed primary treatment with a current Body mass index (BMI) over 30.

Focus Group

Intervention Type OTHER

Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight.

Medical Oncology Clinicians

Oncology providers associated with community-based practices

Focus Group

Intervention Type OTHER

Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Focus Group

Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 21 or older
* Diagnosed with early breast cancer, Stages I-III
* Completed primary treatment (Surgery, chemotherapy, radiation) within past 2 years
* Body mass Index of equal or greater than 30


* Breast cancer oncology provider in North Carolina with MD/DO/PA/NP/RN
* associated with community-based practices

Exclusion Criteria

* Cannot understand and speak English
Minimum Eligible Age

21 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Cancer Society, Inc.

OTHER

Sponsor Role collaborator

Pfizer

INDUSTRY

Sponsor Role collaborator

UNC Lineberger Comprehensive Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kirsten Nyrop, PhD

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LCCC 1954

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Peer Counseling for Weight Loss
NCT00120029 UNKNOWN NA
Prevention of Weight Gain
NCT00011102 COMPLETED NA
The Women's Healthy Lifestyle Study
NCT00583726 COMPLETED NA
Breast Cancer WEight Loss Study (BWEL Study)
NCT02750826 ACTIVE_NOT_RECRUITING PHASE3